{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:30:59Z","timestamp":1790692259271,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Yichang Medical and Health Research Project of 2021"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10528-025-11254-5","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T13:32:39Z","timestamp":1759671159000},"page":"4824-4846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["m6A Modification-Mediated LINC01547 Promotes Pancreatic Cancer Growth and Gemcitabine Resistance Through miR-34a-5p\/MYH9 Axis"],"prefix":"10.1007","volume":"64","author":[{"given":"Guangrui","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,5]]},"reference":[{"issue":"6","key":"11254_CR1","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"HA Burris 3rd","year":"1997","unstructured":"Burris HA 3rd et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6):2403\u20132413","journal-title":"J Clin Oncol"},{"issue":"1","key":"11254_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12943-024-02089-6","volume":"23","author":"D Chen","year":"2024","unstructured":"Chen D et al (2024) Writers, readers, and erasers RNA modifications and drug resistance in cancer. Mol Cancer 23(1):178","journal-title":"Mol Cancer"},{"key":"11254_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2014.07.041","volume":"741","author":"L de Sousa Cavalcante","year":"2014","unstructured":"de Sousa Cavalcante L, Monteiro G (2014) Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer. Eur J Pharmacol 741:8\u201316","journal-title":"Eur J Pharmacol"},{"key":"11254_CR4","doi-asserted-by":"publisher","first-page":"1421763","DOI":"10.3389\/fcell.2024.1421763","volume":"12","author":"Z Gou","year":"2024","unstructured":"Gou Z et al (2024) Exploring the nexus between MYH9 and tumors: novel insights and new therapeutic opportunities. Front Cell Dev Biol 12:1421763","journal-title":"Front Cell Dev Biol"},{"key":"11254_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.critrevonc.2017.03.026","volume":"114","author":"C Grasso","year":"2017","unstructured":"Grasso C, Jansen G, Giovannetti E (2017) Drug resistance in pancreatic cancer: impact of altered energy metabolism. Crit Rev Oncol Hematol 114:139\u2013152","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"11254_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann PC et al (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1(3):313\u2013323","journal-title":"Cell Stem Cell"},{"issue":"9","key":"11254_CR7","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3748\/wjg.v20.i9.2247","volume":"20","author":"M Herreros-Villanueva","year":"2014","unstructured":"Herreros-Villanueva M (2014) Embryonic stem cell factors and pancreatic cancer. World J Gastroenterol 20(9):2247\u20132254","journal-title":"World J Gastroenterol"},{"issue":"1","key":"11254_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12943-022-01501-3","volume":"21","author":"C Hu","year":"2022","unstructured":"Hu C et al (2022) CircFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF\/STAT3 axis. Mol Cancer 21(1):24","journal-title":"Mol Cancer"},{"issue":"7","key":"11254_CR9","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.7150\/ijbs.91832","volume":"20","author":"Y Huang","year":"2024","unstructured":"Huang Y et al (2024) LncRNAs as nodes for the cross-talk between autophagy and Wnt signaling in pancreatic cancer drug resistance. Int J Biol Sci 20(7):2698\u20132726","journal-title":"Int J Biol Sci"},{"issue":"11","key":"11254_CR10","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.4252\/wjsc.v12.i11.1410","volume":"12","author":"P Jagust","year":"2020","unstructured":"Jagust P et al (2020) Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells. World J Stem Cells 12(11):1410\u20131428","journal-title":"World J Stem Cells"},{"issue":"10","key":"11254_CR11","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41419-024-07110-w","volume":"15","author":"Q Jia","year":"2024","unstructured":"Jia Q et al (2024) Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9\/ NOTCH\/ DDR axis in pancreatic ductal adenocarcinoma. Cell Death Dis 15(10):767","journal-title":"Cell Death Dis"},{"issue":"1","key":"11254_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X et al (2021) The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 6(1):74","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"11254_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13578","volume":"57","author":"Y Jin","year":"2024","unstructured":"Jin Y, Fan Z (2024) New insights into the interaction between m6A modification and lncRNA in cancer drug resistance. Cell Prolif 57(4):e13578","journal-title":"Cell Prolif"},{"key":"11254_CR14","doi-asserted-by":"publisher","first-page":"1303151","DOI":"10.3389\/fphys.2023.1303151","volume":"14","author":"S Kim","year":"2023","unstructured":"Kim S (2023) LncRNA-miRNA-mRNA regulatory networks in skin aging and therapeutic potentials. Front Physiol 14:1303151","journal-title":"Front Physiol"},{"issue":"1","key":"11254_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13578-022-00844-0","volume":"12","author":"S Lai","year":"2022","unstructured":"Lai S et al (2022) N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer. Cell Biosci 12(1):125","journal-title":"Cell Biosci"},{"issue":"10","key":"11254_CR16","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1111\/cas.14617","volume":"111","author":"S Li","year":"2020","unstructured":"Li S et al (2020) Lncarsr sponges miR-34a-5p to promote colorectal cancer invasion and metastasis via hexokinase-1-mediated glycolysis. Cancer Sci 111(10):3938\u20133952","journal-title":"Cancer Sci"},{"issue":"15","key":"11254_CR17","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.7150\/ijbs.64851","volume":"17","author":"X Li","year":"2021","unstructured":"Li X et al (2021) Mir-34a-5p functions as a tumor suppressor in head and neck squamous cell cancer progression by targeting Flotillin-2. Int J Biol Sci 17(15):4327\u20134339","journal-title":"Int J Biol Sci"},{"issue":"1","key":"11254_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-024-02041-8","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y et al (2024) The role of RNA methylation in tumor immunity and its potential in immunotherapy. Mol Cancer 23(1):130","journal-title":"Mol Cancer"},{"issue":"1","key":"11254_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13062-022-00347-5","volume":"17","author":"C Lin","year":"2022","unstructured":"Lin C et al (2022) N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway. Biol Direct 17(1):33","journal-title":"Biol Direct"},{"key":"11254_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116118","volume":"171","author":"Q Liu","year":"2024","unstructured":"Liu Q et al (2024) MYH9: a key protein involved in tumor progression and virus-related diseases. Biomed Pharmacother 171:116118","journal-title":"Biomed Pharmacother"},{"key":"11254_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2020.12.012","volume":"75","author":"EM McCabe","year":"2021","unstructured":"McCabe EM, Rasmussen TP (2021) LncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol 75:38\u201348","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"11254_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12943-022-01599-5","volume":"21","author":"L Meng","year":"2022","unstructured":"Meng L et al (2022) Circstx6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2. Mol Cancer 21(1):121","journal-title":"Mol Cancer"},{"issue":"3","key":"11254_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth K et al (2024) Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet 25(3):211\u2013232","journal-title":"Nat Rev Genet"},{"issue":"4","key":"11254_CR24","doi-asserted-by":"publisher","first-page":"165424","DOI":"10.1016\/j.bbadis.2019.02.019","volume":"1866","author":"S Prasad","year":"2020","unstructured":"Prasad S et al (2020) Cancer cells stemness: a doorstep to targeted therapy. Biochimica et Biophysica Acta (BBA) 1866(4):165424","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"11","key":"11254_CR25","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L et al (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913\u20132921","journal-title":"Cancer Res"},{"issue":"2","key":"11254_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12253-016-0124-z","volume":"23","author":"L Sabour","year":"2017","unstructured":"Sabour L, Sabour M, Ghorbian S (2017) Clinical applications of next-generation sequencing in cancer diagnosis. Pathol Oncol Res 23(2):225\u2013234","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"11254_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1615\/CritRevOncog.2019031641","volume":"24","author":"D Sarvepalli","year":"2019","unstructured":"Sarvepalli D et al (2019) Gemcitabine: a review of chemoresistance in pancreatic cancer. Crit Rev Oncog 24(2):199\u2013212","journal-title":"Crit Rev Oncog"},{"issue":"4","key":"11254_CR28","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/cas.13533","volume":"109","author":"N Sasaki","year":"2018","unstructured":"Sasaki N et al (2018) Stemness and anti-cancer drug resistance in ATP-binding cassette subfamily G member 2 highly expressed pancreatic cancer is induced in 3D culture conditions. Cancer Sci 109(4):1135\u20131146","journal-title":"Cancer Sci"},{"issue":"3","key":"11254_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","volume":"182","author":"T Scholzen","year":"2000","unstructured":"Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182(3):311\u2013322","journal-title":"J Cell Physiol"},{"issue":"4","key":"11254_CR30","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.biocel.2004.08.010","volume":"37","author":"SV Shmelkov","year":"2005","unstructured":"Shmelkov SV et al (2005) AC133\/CD133\/Prominin-1. Int J Biochem Cell Biol 37(4):715\u2013719","journal-title":"Int J Biochem Cell Biol"},{"issue":"18","key":"11254_CR31","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1158\/0008-5472.CAN-22-3346","volume":"83","author":"J Su","year":"2023","unstructured":"Su J et al (2023) N 6-methyladenosine modification of FZR1 mRNA promotes gemcitabine resistance in pancreatic cancer. Cancer Res 83(18):3059\u20133076","journal-title":"Cancer Res"},{"issue":"2","key":"11254_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.canlet.2009.01.013","volume":"278","author":"N Ta\u00efeb","year":"2009","unstructured":"Ta\u00efeb N et al (2009) The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif. Cancer Lett 278(2):164\u2013173","journal-title":"Cancer Lett"},{"issue":"7483","key":"11254_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP (2014) The multilayered complexity of ceRNA crosstalk and competition. Nature 505(7483):344\u2013352","journal-title":"Nature"},{"issue":"6","key":"11254_CR34","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1365-2559.2005.02170.x","volume":"46","author":"T Tsukamoto","year":"2005","unstructured":"Tsukamoto T et al (2005) Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology 46(6):649\u2013658","journal-title":"Histopathology"},{"key":"11254_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2016.10.003","volume":"51","author":"ES Villodre","year":"2016","unstructured":"Villodre ES et al (2016) Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis. Cancer Treat Rev 51:1\u20139","journal-title":"Cancer Treat Rev"},{"issue":"3\u20134","key":"11254_CR36","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s10495-024-02070-0","volume":"30","author":"D Wang","year":"2025","unstructured":"Wang D et al (2025) Silencing LINC01547 induces hepatocellular carcinoma cell apoptosis and metastasis inhibition via the ADAR1\/FAK and miR-146b-5p\/RAC1 axes. Apoptosis 30(3\u20134):936\u2013954","journal-title":"Apoptosis"},{"issue":"8","key":"11254_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18015","volume":"9","author":"W Wu","year":"2023","unstructured":"Wu W et al (2023) Long intergenic non-protein-coding RNA 1547 acts as a competing endogenous RNA and exerts cancer-promoting activity in non-small cell lung cancer by targeting the microRNA-195-5p\/ homeobox C8 axis. Heliyon 9(8):e18015","journal-title":"Heliyon"},{"issue":"6","key":"11254_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2020.151576","volume":"122","author":"XP Xu","year":"2020","unstructured":"Xu XP et al (2020) MiR-34a-5p suppresses the invasion and metastasis of liver cancer by targeting the transcription factor YY1 to mediate MYCT1 upregulation. Acta Histochem 122(6):151576","journal-title":"Acta Histochem"},{"issue":"7","key":"11254_CR39","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41419-024-06876-3","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y et al (2024) LINC01133 promotes pancreatic ductal adenocarcinoma epithelial-mesenchymal transition mediated by SPP1 through binding to Arp3. Cell Death Dis 15(7):492","journal-title":"Cell Death Dis"},{"issue":"7","key":"11254_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12484","volume":"13","author":"H Yao","year":"2024","unstructured":"Yao H et al (2024) Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-A in pancreatic cancer. J Extracell Vesicles 13(7):e12484","journal-title":"J Extracell Vesicles"},{"key":"11254_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184504","author":"S Zeng","year":"2019","unstructured":"Zeng S et al (2019) Chemoresistance in pancreatic cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20184504","journal-title":"Int J Mol Sci"},{"issue":"11","key":"11254_CR42","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.62347\/PNKH7683","volume":"14","author":"S Zhang","year":"2024","unstructured":"Zhang S et al (2024) The small protein LINC01547-ORF inhibits colorectal cancer progression by regulating the CLDN18-FAK-AKT axis. Am J Cancer Res 14(11):5504\u20135520","journal-title":"Am J Cancer Res"},{"issue":"1","key":"11254_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12864-023-09209-4","volume":"24","author":"Z Zhao","year":"2023","unstructured":"Zhao Z et al (2023) Multi-level integrative analysis of the roles of lncRNAs and differential mRNAs in the progression of chronic pancreatitis to pancreatic ductal adenocarcinoma. BMC Genomics 24(1):101","journal-title":"BMC Genomics"},{"issue":"1","key":"11254_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12514","volume":"52","author":"C Zhou","year":"2019","unstructured":"Zhou C et al (2019) Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1. Cell Prolif 52(1):e12514","journal-title":"Cell Prolif"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11254-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-025-11254-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11254-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:08:29Z","timestamp":1784621309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-025-11254-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,5]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["11254"],"URL":"https:\/\/doi.org\/10.1007\/s10528-025-11254-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6889602\/v1","asserted-by":"object"}]},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,5]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies were reviewed and approved by the Ethics Committee of China Three Gorges University (No: 2024031U). This study follows the principles according to the Declaration of Helsinki, with fully informed consent obtained from all participants before sample collection. The animal study was conducted in accordance with ARRIVE guidelines and approved by Animal Ethics Committee of China Three Gorges University. This study does not involve clinical trial.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors read and provided consent to publish this manuscript in the\n                      Biochemical Genetics.","order":3,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}}]}}